Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab as Preoperative Adjunct in PDR
NCT00931125Phase 2Unknown
- Start
- Mar 2009
- Primary completion
- Sep 2013
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in proliferative diabetic retinopathy (PDR). Status: unknown.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT00931125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931125.